Figure 2
Figure 2. CML progenitor cell treatment with BCR-ABL1 TKIs leads to an abrogation of STAT5 signaling essential for survival and proliferation of the cell.

CML progenitor cell treatment with BCR-ABL1 TKIs leads to an abrogation of STAT5 signaling essential for survival and proliferation of the cell.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal